Compare State Street SPDR S&P Biotech ETF (XBI) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Zscaler Inc — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.5, while Zscaler Inc trades at $148.6 (market cap $24.23B). The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Zscaler Inc nearer its low. Which is the better fit depends on your goals.
| XBI | ZS | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $164.28 | $336.27 |
52-Week Low | $85.16 | $118.05 |
Market Cap | — | $24.23B |
Enterprise Value | — | $22.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
